Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C31H27BrO3S |
Molecular Weight | 559.513 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C)C2=C(S1)C(Br)=C3C=CC=CC3=C2C4=CC(C)=C(O[C@H](CC5=CC=CC=C5)C(O)=O)C(C)=C4
InChI
InChIKey=FONCZICQWCUXEB-RUZDIDTESA-N
InChI=1S/C31H27BrO3S/c1-17-14-22(15-18(2)29(17)35-25(31(33)34)16-21-10-6-5-7-11-21)27-23-12-8-9-13-24(23)28(32)30-26(27)19(3)20(4)36-30/h5-15,25H,16H2,1-4H3,(H,33,34)/t25-/m1/s1
Ertiprotafib was originally developed as an inhibitor of PTP1B. Multiple targets of ertiprotafib, in addition to PTP1B inhibition, have been suggested including dual PPARalpha/PPARgamma agonism and IKK-beta inhibition. It normalized the plasma glucose and insulin levels in diabetic animal models and progressed to a phase II clinical trial for the treatment of Type 2 diabetes mellitus. Ertiprotafib development has been discontinued.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P18031 Gene ID: 5770.0 Gene Symbol: PTPN1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24148325 |
0.87 µM [IC50] | ||
Target ID: O14920 Gene ID: 3551.0 Gene Symbol: IKBKB Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17407812 |
400.0 nM [IC50] |
PubMed
Title | Date | PubMed |
---|---|---|
PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta). | 2007 May 15 |
|
2-Acyl-tetrahydroisoquinoline-3-carboxylic acids: lead compounds with triple actions, peroxisome proliferator-activated receptor α/γ agonist and protein-tyrosine phosphatase 1B inhibitory activities. | 2011 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29711
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
157049
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL184041
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
100000127790
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
251303-04-5
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
DTXSID30179814
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
NN-52
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
DB06521
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
8226
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
C498182
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
5TPM2EB426
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
SUB33914
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY | |||
|
C81694
Created by
admin on Sat Dec 16 16:50:49 GMT 2023 , Edited by admin on Sat Dec 16 16:50:49 GMT 2023
|
PRIMARY |
ACTIVE MOIETY